investors call
The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
The company fielded a major spike in demand and now paints a rosy long-term picture for its telehealth business, although its poor EPS disappointed some investors.
Although it's still operating in the red, the digital chronic disease management company logged 149% revenue growth in 2019.